Entresto Contraindications

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Contraindications

Hypersensitivity to the active substance, sacubitril, valsartan, or to any of the excipients.
Concomitant use with ACE inhibitors (see PRECAUTIONS, DOSAGE & ADMINISTRATION and INTERACTIONS). Entresto must not be administered until 36 hours after discontinuing ACE inhibitor therapy.
Known history of angioedema related to previous ACE inhibitor or ARB therapy.
Hereditary angioedema.
Concomitant use with aliskiren in patients with Type 2 diabetes (see PRECAUTIONS and INTERACTIONS).
Pregnancy (see USE IN PREGNANCY & LACTATION).

Entresto Contraindications

sacubitril + valsartan

Manufacturer:

Novartis

Distributor:

Zuellig Pharma